Found 25 matching trials
Immunotherapy Plus Chemotherapy vs. Chemoradiotherapy for Thoracic Squamous Esophageal Carcinoma
PHASE2The investigators conducted a phase II, prospective, two-arm clinical study...
Location
Fujian Medical University Union Hospital
Toxicity and Outcome of Whole Breast Hypofractionated Radiotherapy: a Single Institution Experience
N/AThis is a homogeneous, single institution, observational, non-interventiona...
Status
Active Not Recruiting
Location
IRCCS San Raffaele Scientific Institute
Study of Vinorelbine and Cisplatin as Induction Therapy With Radiotherapy in Patients With Unresectable NSCLC
PHASE2Phase II clinical trial with metronomic oral vinorelbine and tri-weekly cis...
Location
Hospital General Universitario de Elche
APBI: 27Gy in 5 Fractions for Early Breast Cancer
NAThis study will test the safety of partial breast RT using 27Gy in 5 daily ...
Location
Tom Baker Cancer Centre
Accelerated Hypofractionated 1 Week Radiotherapy in Breast Cancer Patients
PHASE3Accelerated hypofractionated 1 week post-mastectomy chest wall irradiation ...
Location
Zagazig university hospitals
Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer
PHASE2Nab-paclitaxel and carboplatin showed better treatment response compared wi...
Location
Hangzhou Cancer Hospital
Dose-escalated Adaptive Radiotherapy of Thoracic Disease for Small Cell Lung Cancer
PHASE2The purpose of this study is to find out what effects of using adaptive rad...
Location
Cross Cancer Institute
Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer
PHASE2Nab-paclitaxel and carboplatin showed better treatment response compared wi...
Location
Zhongnan Hospital of Wuhan University
Prospective Study on Factors Predicting Chemo-Radiotherapy Induced Pulmonary and Esophageal Injury
N/AThe purpose of this study is to evaluate clinical, dosimetrical, functional...
Location
Fudan University, Cancer Hospital, Department of Radiation Oncology
Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer
PHASE1This phase I trial studies how well giving bevacizumab together with paclit...
Location
University of Chicago